Androgen receptor antagonists: a patent review (2008-2011).
about
Targets to treat androgen excess in polycystic ovary syndrome.Carnosic acid promotes degradation of the androgen receptor and is regulated by the unfolded protein response pathway in vitro and in vivo.Enhanced inhibition of prostate tumor growth by dual targeting the androgen receptor and the regulatory subunit type iα of protein kinase a in vivoThe discovery of novel human androgen receptor antagonist chemotypes using a combined pharmacophore screening procedure.
P2860
Androgen receptor antagonists: a patent review (2008-2011).
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Androgen receptor antagonists: a patent review (2008-2011).
@en
type
label
Androgen receptor antagonists: a patent review (2008-2011).
@en
prefLabel
Androgen receptor antagonists: a patent review (2008-2011).
@en
P2093
P2860
P1476
Androgen receptor antagonists: a patent review (2008-2011).
@en
P2093
Charles B Duke
Christopher C Coss
Duane D Miller
Michael L Mohler
Shivaputra A Patil
P2860
P304
P356
10.1517/13543776.2012.682571
P407
P577
2012-05-01T00:00:00Z